Compare · DFTX vs PM
DFTX vs PM
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Philip Morris International Inc (PM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and PM operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- PM is the larger of the two at $278.50B, about 70.6x DFTX ($3.95B).
- DFTX has been more active in the news (21 items in the past 4 weeks vs 8 for PM).
- PM has more recent analyst coverage (25 ratings vs 5 for DFTX).
- Company
- Definium Therapeutics Inc.
- Philip Morris International Inc
- Price
- -
- -
- Market cap
- $3.95B
- $278.50B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 21
- 8
- Recent ratings
- 5
- 25
Philip Morris International Inc
Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other nicotine-containing products, smoke-free products, and related electronic devices and accessories. The company offers IQOS smoke-free products, including heated tobacco and nicotine-containing vapor products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, and Parliament HeatSticks brands, as well as under the Fiit and Miix licensed brands. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, South and Southeast Asia, East Asia, Australia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.
Latest DFTX
- Needham reiterated coverage on Definium Therapeutics with a new price target
- Definium Therapeutics, Inc. Announces Proposed Public Offering
- SEC Form 424B5 filed by Definium Therapeutics Inc.
- Chief Medical Officer Karlin Daniel was granted 100,000 shares, increasing direct ownership by 24% to 513,317 units (SEC Form 4)
- Chief Executive Officer Barrow Robert was granted 375,000 shares, increasing direct ownership by 50% to 1,127,454 units (SEC Form 4)
- Chief Legal Officer Sullivan Mark was granted 62,500 shares, increasing direct ownership by 23% to 333,579 units (SEC Form 4)
- Chief Financial Officer Roberts Brandi was granted 62,500 shares, increasing direct ownership by 42% to 212,500 units (SEC Form 4)
- Chief Commercial Officer Wiley Matthew T. was granted 62,500 shares, increasing direct ownership by 54% to 177,500 units (SEC Form 4)
- Definium Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
Latest PM
- WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated Future
- Philip Morris International Announces New Regional Leadership
- Amendment: Philip Morris International Inc filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Philip Morris International Declares Regular Quarterly Dividend of $1.47 Per Share
- Counterfeit Cigarettes Drive EU Illicit Market Above 10% for First Time Since 2014
- Philip Morris International Inc filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Philip Morris International Participates in 2026 dbAccess Global Consumer Conference; Updates 2026 Full-Year Diluted EPS Forecast for Currency and Non-Cash Impairment Only
- Philip Morris International to Host Webcast of Presentation at the 2026 dbAccess Global Consumer Conference
- SEC Form SD filed by Philip Morris International Inc